---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-008787"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2024-07-10T23:59:59+00:00"
generated_at: "2026-05-31T22:10:08.903215+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Catheter Precision shareholders approve reverse stock split, authorize share decrease

## Summary
- James Caruso and Andrew Arno elected as Class III directors with ~2.6M votes each.
- Amendment to reduce authorized common stock approved by ~4.07M votes.
- Reverse stock split (1:5 to 1:15) authorized by ~3.99M votes.
- 2M additional shares for 2023 Equity Incentive Plan approved by ~2.36M votes.
- Nonbinding vote on executive compensation set to every three years based on shareholder preference.

## SEC filing metadata
- accession: 0001654954-24-008787
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2024-07-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000165495424008787/0001654954-24-008787-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000165495424008787/rmed_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-008787
- JSON: https://secwatch.observer/filing/0001654954-24-008787.json
- Plain text: https://secwatch.observer/filing/0001654954-24-008787.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.